Cancel

Metastatic Prostate Cancer: Current Trends and Future Landscape

Learning Objectives: At the completion of this activity, participants should be better able to: 1. Communicate with patients and colleagues about the pathophysiology, risk factors, symptoms, and genetics of prostate cancer. 2. Create individualized treatment plans for patients with prostate cancer based on current screening and staging guidelines and evidence for monotherapy, combination therapy, and sequencing of therapies. 3. Evaluate data for the benefits and risks of current an...
Applied Clinical Education

ASCCP2018 Annual Meeting

The 2018 Annual Meeting will focus on the underserved and underscreened populations with special focus on transgender and immunocompromised patients. In addition, the program will also include sessions on vulvar and vaginal neoplasia, anal cancer, colposcopy, sexually transmitted diseases and much more! This interdisciplinary meeting will appeal to a wide variety of medical and research professionals including, but not limited to: Obstetricians & Gynecologists Gynecologic Oncologists F...
American Society for Colposcopy and Cervical Pathology - ASCCP

Occurrence and Implications of Chemotherapy-Induced Nausea and Vomiting (CINV)

Oncology nursing professionals play a key role in the care of patients receiving chemotherapy. However, to do so, they require access to the most recent clinical information and guidance, the latest developments in CINV therapy, and expanded knowledge of CINV pathophysiology. In addition, oncology nursing professionals need continuing education focused on appropriate screening in order to better identify patients at risk of CINV before chemotherapy begins, and developing the skills to undertak...
American Academy of CME

Immunotherapy: Harnessing the Immune System to Treat Cancer

This educational activity is directed toward oncology nurses and nurse practitioners caring for patients receiving cancer immunotherapy. Learning Objectives Upon completion of this activity, the participant will be able to: 1. List the various types of immunotherapy currently used in the management of malignancies 2. Summarize the various mechanisms of action for the different immunotherapy agents 3. Describe various toxicities for specific types of immunotherapy 4. Explain specific...
Medical Learning Institute

Patient-Centered Care of Metastatic Colon and Rectal Cancer

This educational activity is directed toward oncology nurses and nurse practitioners who have expressed a need for educational programming on the coordination of care, management of adverse events, counseling and education, and patient follow-up in metastatic colon and rectal cancer (mCRC). Such education would allow these healthcare professionals to take on leadership roles in the multi-disciplinary care of mCRC, leading to improved patient outcomes. Learning Objectives At the conclusion...
Medical Learning Institute

Hematology/Oncology PICU Issues: Case Studies

Learning Objectives: Review the importance of hemoglobin, coagulation, bone marrow, fibrinolytic and transfusion issues with the critically ill child. Describe the diagnostic laboratory data necessary to care for the child with anemia, platelet disorders, and oncologic emergencies. Prioritize the care for the child with an oncologic emergency.
Contemporary Forums

Abnormal Breast Findings: When to Follow, When to Refer

Learning Objectives: Discuss breast symptoms including palpable findings, mastodynia, nipple discharge, skin changes, inflammation and imaging changes. Describe assessment, diagnosis and management of breast symptoms. Recognize breast changes to refer for specialty evaluation and treatment.
Contemporary Forums

Update on Nursing Management of Cancer Therapy-Related Dermatologic Toxicities

STATEMENT OF NEED Many patients who receive novel targeted therapies and immunotherapies develop dermatologic toxicities that are associated with impaired quality of life due to sequelae such as pain, pruritus, and anxiety. The type and severity of dermatologic toxicity can vary significantly between classes of agents and pose distinct nursing management challenges in prophylaxis, treatment, and monitoring. For example, patients receiving EGFR inhibitors or immune-checkpoint inhibitors (eg,...
i3 Health

The Oncologist: A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A KSWOG Study

Learning Objectives: 1. Discuss the incidence associated with secondary adrenal suppression related to antiemetic dexamethasone therapy in cancer patients receiving chemotherapy. 2. Discuss the associated factors with secondary adrenal suppression related to antiemetic dexamethasone therapy in cancer patients receiving chemotherapy. 3. Describe the potential for adrenal insufficiency secondary to antiemetic dexamethasone therapy in cancer patients receiving chemotherapy.. Background. In...
Society For Translational Oncology

The Oncologist: Ramosetron Vs Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea & Vomiting: Randomized Phase III Trial

Learning Objectives: 1. Compare ramosetron to ondansetron in combination with aprepitant and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic drugs. 2. Discuss the safety of ramosetron in combination with aprepitant and dexamethasone. 3. Discuss subpopulations and conditions that may affect the effectiveness of ramosetron. Background. A combination of serotonin receptor (5-hydroxytryptamine receptor ty...
Society For Translational Oncology

Impact of Human Papillomavirus (HPV)

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, infecting more than 6 million new people each year. At least 50% of sexually active people will be infected with HPV at some point during their lifetime. More than 200 strains of HPV have been identified with results of infection ranging the spectrum from genital warts to multiple types of cancers. Three vaccines active against the HPV strains most commonly involved in development of genital wart...
freeCE.com

Self-Care Specialist (SCS) Unit 4: Women's Health

Women are generally not too shy in asking questions in the "Feminine Hygiene" aisle. They are very proactive about their health and given a private area, they will specifically tell you what symptoms they are having. This activity is an overview to women's most frequent health issues, including vaginal infections, urinary tract infections and menstrual maladies. We will discuss the number of sexual lubricants that are available and select the right ones be it for a woman wanting to conceive or...
freeCE.com

Diagnostics for Invasive Fungal Infections-New and Old

Target audience The enduring activity is intended for health care professionals, particularly physicians, clinical microbiologists, researchers, nurse, nurse practitioners and pharmacists, specializing in prevention and management of fungal infections. Learning objectives Upon completion of the educational activity, participants should be able to: -Discuss the role of new and old diagnostics in the prevention and management of invasive fungal infections Method of Participation In ord...
AKH Inc. Advancing Knowledge in Healthcare

IFIs: Epidemiological Trends, Antifungal Resistance, and Why Antifungal Therapy Fails in Patients with Invasive Mold Infections

Target audience The enduring activity is intended for health care professionals, particularly physicians, clinical microbiologists, researchers, nurse, nurse practitioners and pharmacists, specializing in prevention and management of fungal infections. Learning objectives Upon completion of the educational activity, participants should be able to: -Discuss the role of prophylaxis therapy in patients with invasive fungal infections (IFIs) -Review the emerging data on breakthrough and rel...
AKH Inc. Advancing Knowledge in Healthcare

PSA Testing for Prostate Cancer (CE)

At the conclusion of this course you should be able to list: The two ways PSA is used by doctors Three things that raise PSA Three side effects of treating prostate Cancer The current recommendations on 'screening' for prostate Cancer
CACMLE

The Case for Integration of Locoregional Therapy with Systemic Therapy in Patients with Metastatic Colorectal Cancer (mCRC)

•Evaluate when IO techniques can be proposed in the treatment algorithm •Discuss conceptual arguments to integrate locoregional therapy (radio-embolization) into our current treatment algorithm
The France Foundation

Colorectal Cancer and Colorectal Liver Metastases — Epidemiology

•Identify the age and gender specific incidence of CRC •Describe the incidence of CRC based on tumor location •Evaluate the stage distribution of CRC at presentation
The France Foundation

Diagnosis and Staging of CRC Liver Metastases

•Use imaging to diagnose and stage metastatic liver disease in patients with colorectal cancer
The France Foundation

Ablation vs Surgery: Colon Cancer Liver Metastases

•Discuss the available loco-regional therapies proposed by Interventional Oncology •Evaluate the results of the current literature for ablation, TACE and radio-embolization
The France Foundation

Comprehensive Colposcopy

This evidence-based course is designed for the beginning/intermediate colposcopist. It will also benefit clinicians needing updated information about the newly published 2012 Cervical Cancer Screening Guidelines, the Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors, and new concepts about HPV screening and triage, treatment methods, and HPV epidemiology. The course is designed to improve competencies I medical knowledge, practice-based le...
American Society for Colposcopy and Cervical Pathology - ASCCP

The Oncologist: A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience

Learning Objectives: 1. Coordinate care of patients with new or progressive breast cancer brain metastases between medical and radiation oncology and neurosurgery in order to preserve neurological function and quality of life. 2. Discuss the ability of a multidisciplinary clinic to provide comprehensive care to patients with breast cancer brain metastases. Background. Breast cancer brain metastasis (BCBM) confers a poor prognosis and is unusual in requiring multidisciplinary care in the ...
Society For Translational Oncology

The Oncologist: Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives

Learning Objectives: 1. Explain the process for diagnosis of neuroendocrine carcinoma of the breast. 2. Describe the clinical and pathological features of neuroendocrine carcinoma of the breast. Neuroendocrine carcinoma of the breast is considered a rare entity, and for this reason there are no data from prospective clinical trials on its optimal management. Early stage tumors are usually treated with the same strategy used for the other types of invasive breast cancer. Anthracycline- and...
Society For Translational Oncology

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to improved treatment options, the 5-year survival rate for MBC remains poor. Fortunately, emerging agents, such as targeted therapies, including the novel class of cyclin-dependent kinase (CDK) 4/6 inhibitors, may improve outcomes for patients with MBC. This CME activity will review the mechanisms of action of new and emerging targeted therapies, as well as evaluate the latest clinica...
Slack Inc.

The Oncologist: Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma

Learning Objectives: 1. Cite the similarities and differences in detecting circulating tumor cells, circulating tumor DNA, and circulating mRNA in melanoma. 2. Discuss the potential for application of circulating tumor products in screening, diagnosis, prognosis, prediction, and genetic or molecular characterization of melanoma. 3. Describe the potential for future research and discovery through circulating tumor products. Circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), an...
Society For Translational Oncology

Physical Examination of the Female Cancer Patient with Sexual Concerns: What Oncologists and Patients Should Expect from Consultation with a Specialist

After reading the article “Physical Examination of the Female Cancer Patient with Sexual Concerns: What Oncologists and Patients Should Expect from Consultation with a Specialist,” the learner should be able to: 1. Review aspects of the physical examination of the female cancer patient with sexual concerns. 2. Describe the specialist expertise needed when referring patients for treatment of female patients with cancer and sexual function concerns. 3. Interpret specialist findings and...
American Cancer Society

Cancer Screening in the United States, 2016: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening

After reading the article “Cancer Screening in the United States, 2016: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening ,” the learner should be able to: 1. Discuss American Cancer Society guidelines for early detection of breast, colorectal, cervical, lung, and prostate cancers. 2. Provide patients with guidance regarding appropriate early detection options. 3. Answer questions from patients regarding emerging cancer detection technologi...
American Cancer Society

Melanoma 2018: 28th Annual Cutaneous Malignancy Update

As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the cour...
Scripps Health

Impact of Human Papillomavirus (HPV)

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, infecting more than 6 million new people each year. At least 50% of sexually active people will be infected with HPV at some point during their lifetime. More than 200 strains of HPV have been identified with results of infection ranging the spectrum from genital warts to multiple types of cancers. Three vaccines active against the HPV strains most commonly involved in development of genital wart...
freeCE.com

The Oncologist: Racial Differences in Tobacco Cessation and Treatment Utilization Following Lung Screening: An Examination of the National Lung Screening Trial

Learning Objectives: 1. Identify smoking behaviors among black and white smokers undergoing screening for lung cancer. 2. Describe referral to and uptake of smoking cessation aids and programs. 3. Identify potential barriers to sustained smoking cessation among black and white smokers and compare racial differences in quit activity between the two groups. Background. Black smokers have demonstrated greater lung cancer disease burden and poorer smoking cessation outcomes compared with wh...
Society For Translational Oncology

Combination Strategies in Melanoma Management: What’s New and What’s Next

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is often curable if caught early, treatment options are limited for patients with advanced disease. In almost all cases, death is caused by widespread metastatic disease. Fortunately, an improved understanding of the genetic impact of the disease, earlier detection, appropriate staging, and a treatment revolution that has brought new targeted as well as immunotherapies to clinic has...
Slack Inc.

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately 10,130 disease-related deaths. Recent advances in the understanding of the underlying biology of melanoma have resulted in the identification of new novel targets for therapy, resulting in significant improvements to clinical outcomes for patients with advanced disease. As these newer agents, specifically immune checkpoint inhibitors, are incorporated into everyday clinical prac...
Slack Inc.

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and prognosis, and the selection of tailored therapy. Common somatic mutations in melanoma have been utilized to predict response to targeted therapy leading to improved clinical outcomes in patients with advanced disease. As targeted treatment strategies continue to evolve, it is essential that clinicians caring for patients with advanced melanoma are familiar with recent clinical ad...
Slack Inc.

Pathology Update 2018: What you need to know about new AJCC staging and WHO classifications

Dr. Mahul Amin, editor of the 8th edition of the AJCC Cancer Staging Manual, joins an elite roster of speakers for this third annual 2.5-day general surgical pathology course. Covering a broad range of subjects in diagnostic pathology, the central themes for this year's course include staging changes found in the 8th edition of the AJCC tumor staging manual, and updates in WHO classification. Organ systems discussed include breast, head and neck, gastrointestinal, pulmonary, soft tissue, gyn...
Mayo Clinic

Human Papillomavirus: What the Clinician Should Know 2014 Highlights

Human papillomavirus- related oropharyngeal cancer has reached epidemic proportions. The aim of this course is to familiarize the clinician with the risk factors for HPV- malignancy, screening techniques, and management options. Further, the aim is to understand the differences between HPV negative and HPV- positive disease with regard to treatment options and prognosis. The course is based on current evidence and includes a review of the appropriate literature. Outcome Objectives At the...
American Academy of Otolaryngology - Head & Neck Surgery Foundation

Self-Care Specialist (SCS) Unit 4: Women's Health

Women are generally not too shy in asking questions in the "Feminine Hygiene" aisle. They are very proactive about their health and given a private area, they will specifically tell you what symptoms they are having. This activity is an overview to women's most frequent health issues, including vaginal infections, urinary tract infections and menstrual maladies. We will discuss the number of sexual lubricants that are available and select the right ones be it for a woman wanting to conceive or...
freeCE.com

39th Annual Intensive Review of Internal Medicine: Harvard Medical School and Brigham and Women's Hospital Board Review

Ace the ABIM Board Examinations with the 39th Annual Intensive Review of Internal Medicine. This course is specifically oriented to preparing you for the Board Examinations.  Topics include:  Acute Kidney Injury, Chronic Kidney Disease, Hypercoagulable States and New Anticoagulants, Board Review in Hematology, Acute and Chronic Pancreatitis, Prostate and Bladder Cancer, Cardiology Overview for the Boards and many others. After viewing 39th Annual Intensive Review of Internal Medicine, you...
CMEInfo

Medical Risk Management CME (MedRisk)

Medical Risk Management CME (MedRisk) provides online CME focusing on risk management, patient safety and medical error prevention. MedRisk offers over 50 courses for physicians, dentists and nurses. Representative topics include preventing medical errors; avoiding "never" events; avoiding medical systems failures; low health literacy; cultural competency; medical ethics; electronic medicine; documentation; failure to diagnose; failure to diagnose cancer; managing disruptive physician behavio...
Medical Risk Management

Updates in Cardio-Oncology 2018: Challenges and New Frontiers

This course reviews clinically important information regarding the management of cardiac and vascular diseases affecting patients with cancer and cancer survivors. The interactive, practice-based format includes case presentations and state-of-the-art lectures in recent and topical developments in this emerging field. The goal is to improve quality, safety and outcomes for patients within the dynamic and interactive educational experience. The current state of knowledge of common cardiovascula...
Mayo Clinic

Updates in General Internal Medicine for Specialists 2018

Advances, Updates, Guidelines, and Best Practices in General Internal Medicine—Expressly for Specialists In this special program, Harvard Medical School's leading clinical faculty, representing more than 30 fields of medicine, share updates and provide recommendations to ensure you are current with the recent advances in general internal medicine that impact the specialists—especially with clinical practice in relevant disciplines outside of your field of expertise. Whether you are a psy...
Harvard Medical School Department of Continuing Education

Rectal Cancer: Updates in Staging and Treatment

This course spans the staging and treatment of patients with rectal cancer, with a focus on new developments and controversies in staging, duration of chemotherapy, and a variety of surgical approaches. Join colleagues from around the Pacific Northwest to learn about the risks and benefits of shorter duration of curative chemotherapy, a major new development in colorectal cancer. Differing staging techniques including controversies about optimal modalities with MRI and endo-rectal ultrasoun...
Virginia Mason

The Oncologist: How Cancers Escape Immune Destruction and Mechanisms of Action for the New Significantly Active Immune Therapies: Helping Non-Immunologists Decipher Recent Advances

Learning Objectives: 1. Explain how cancer can escape normal immune system control. 2. Discuss the ability of new immune therapies to counteract cancers’ ability to escape immune cell mediated death. With the Food and Drug Administration and other worldwide regulatory authorities’ approval of ipilimumab (Yervoy), sipuleucel-T (Provenge), nivolumab (Opdivo), and pembrolizumab (Keytruda), oncologic therapy has now moved into noncancer cell targets within the immune system. For many noni...
Society For Translational Oncology

11th Annual Multidisciplinary Transoral Surgery for Head and Neck Cancer

The Multidisciplinary Transoral Surgery for Head and Neck Cancer course is designed to give otolaryngologists, head and neck surgeons, radiation oncologists, medical oncologists, oral maxillofacial surgeons, pathologists and speech pathologists, a focused educational experience in transoral endoscopic techniques for resecting primary head and neck tumors. In addition, the associated state-of-the-art application of advanced radiotherapy techniques including proton beam therapy and systemic the...
Mayo Clinic

The Oncologist:Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients

Learning Objectives: 1. Explain the role of thyrotropin suppression therapy in thyroid cancer patients. 2. Discuss implications of thyrotropin suppression therapy on bone in different thyroid cancer population groups. 3. Evaluate the necessity of tailored treatment for groups at risk for skeletal adverse events from thyrotropin suppression therapy. Background. The thyroid cancer incidence is rising. Despite current guidelines, controversy exists regarding the degree and duration of thyr...
Society For Translational Oncology

WEBINAR: Providing Pharmaceutical Care for Small Animals

Summary This activity will provide participants with a working knowledge of the most common principles of therapy, toxicology, regulations and counseling points related to small animal patients. This will assist the participant in providing optimal pharmaceutical care. Objectives: 1. Identify important anatomical and physiological considerations that influence drug therapy in small animal patients. 2. Discuss important toxicology considerations for dispensing medications for use in sma...
American College of Veterinary Pharmacists

The Impact of Comorbidity on Cancer and Its Treatments

After reading the article “The Impact of Comorbidity on Cancer and Its Treatments,” the learner should be able to: 1. Discuss the presence and impact of comorbidities on dancer diagnosis, treatment and outcomes. 2. Identify strategies to address comorbidities in cancer patients.
American Cancer Society

Women's Health Bahamas Cruise

Topics: 1.Hereditary Cancer Syndromes in Women 2.Modern Treatment of Abnormal Uterine Bleeding 3.Amenorrhea – Diagnosis and Treatment 4.Current Status of Screening and Prevention of HPV disease 5.Menopause in the 21st century 6.Evidence Based Medicine 7.Controversies in contraception – Everything old is new 8. Anemia in pregnancy 9.Hirsutism and PCOS 10. Chronic venous insufficiency 11. Cord blood. Collection and applications 12. Autoimmune disease 13.Vaginitis revisited 14. ...
Continuing Education, Inc

Clinical and Multidisciplinary Hematology & Oncology: The 15th Annual Review

This course will include a comprehensive update and management strategies of issues in hematologic and oncologic malignancies presenting new disease classification, treatment, and challenging cases. Course topics will focus on key hematologic diseases (dysproteinemias, acute and chronic leukemias, lymphomas), key solid tumors (breast, thoracic, GI, GU), and overlap topics of supportive, ancillary and diagnostic care. The course offers challenging and interactive sessions on pertinent issues in...
Mayo Clinic

The Oncologist: The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases

Learning Objectives: 1. Explain the role of radiosurgery in the treatment of brain metastasis. 2. Describe the rational design and use of targeted therapies in solid malignancy. 3. Cite the current safety and efficacy data on combination targeted therapy and radiosurgery. Brain metastases are the most common intracranial malignancy. Many approaches, including radiation therapy, surgery, and cytotoxic chemotherapy, have been used to treat patients with brain metastases depending on the pa...
Society For Translational Oncology

The Oncologist: Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas

Learning Objectives: 1. Cite the characteristics and natural history of radioiodine refractory differentiated thyroid carcinomas. 2. Assess outcomes (overall and cancer-specific survivals) and prognostic factors of radioiodine refractory differentiated thyroid carcinomas. 3. Identify patients with the worst prognosis to treat with targeted therapy and patient with indolent disease to follow-up. Background. Outcomes vary among patients with radioiodine refractory (RR) differentiated thyr...
Society For Translational Oncology

The Oncologist: Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version

Learning Objective: 1. Use the modified G8 screening tool to facilitate selection for a full GA in older cancer patients. Background. A multidimensional geriatric assessment (GA) is recommended in older cancer patients to inventory health problems and tailor treatment decisions accordingly but requires considerable time and human resources. The G8 is among the most sensitive screening tools for selecting patients warranting a full GA but has limited specificity. We sought to develop and v...
Society For Translational Oncology

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.